SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

Novavax (NVAX)

Add NVAX Price Alert      Hide Sticky   Hide Intro
Moderator: XenaLives
Search This Board:
Last Post: 12/8/2016 5:02:52 PM - Followers: 196 - Board type: Free - Posts Today: 0


Novavax, Inc. (Nasdaq: NVAX) is a clinical-stage biopharmaceutical company creating recombinant protein nanoparticle vaccines to address a broad range of infectious diseases. The company is developing a portfolio of vaccine candidates targeting seasonal and pandemic influenza (H5N1), a vaccine designed to protect children and the elderly against respiratory syncytial virus (RSV), rabies and other candidates. In addition, the company is developing its vaccine candidates for worldwide commercialization including:

Our world-class scientific team is using VLP technology to tackle influenza viruses – including avian strains that have the potential to cause a pandemic outbreak. Our team has created vaccine candidates that are in various phases of clinical testing designed to protect against various circulating strains of pandemic influenza including H1N1 and H5N1, as well as seasonal influenza. Our recombinant nanoparticle protein micelle technology targeted at RSV has been tested in various preclinical studies and has now advanced into clinical testing.

Our vision is to control the spread of infectious diseases by using a unique single-use manufacturing system that allows for the rapid mass production of recombinant protein nanoparticle vaccines. Our goal is to be able to rapidly deliver a customized vaccine in the midst of a declared pandemic.


President and Chief Executive Officer
Stanley C. Erck

Senior Vice President, Research and Development
Gregory M. Glenn, M.D.

Senior Vice President, Manufacturing and Process Development
Timothy J. Hahn, Ph.D.

Senior Vice President, Chief Financial Officer and Treasurer
Barclay A. "Buck" Phillips

Senior Vice President, Business Development
Russell P. "Rip" Wilson

Vice President, Regulatory Affairs
Amy B. Fix

Vice President, Chief Medical Officer
Louis F. Fries III, M.D.

Vice President, Manufacturing
Mervyn L. Hamer

Vice President, General Counsel and Corporate Secretary
John A. Herrmann III, J.D.

Vice President, Process Development
Erica Shane, Ph.D.

Vice President, Vaccine Development
Gale Smith, Ph.D.

Vice President, Clinical Operations
D. Nigel Thomas, Ph.D.



Novavax’s clinical program includes vaccine candidates designed to address infectious diseases worldwide. Using innovative virus-like particle (VLP) and recombinant nanoparticle technology, as well as new and efficient manufacturing approaches, the company produces vaccine candidates to combat diseases, with the goal of allowing countries to better prepare for and more effectively respond to rapidly spreading infections. Our clinical pipeline is shown below.






  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
NVAX News: Statement of Changes in Beneficial Ownership (4) 12/07/2016 04:31:23 PM
NVAX News: Novavax to Participate in the 4th Annual Guggenheim Boston Healthcare Conference 12/06/2016 04:05:33 PM
NVAX News: Novavax to Participate in the 4th Annual Guggenheim Boston Healthcare Conference 12/06/2016 04:05:00 PM
NVAX News: Novavax to Participate in the Citi 2016 Global Healthcare Conference 11/30/2016 04:05:48 PM
NVAX News: Novavax to Participate in the Citi 2016 Global Healthcare Conference 11/30/2016 04:05:00 PM
#3702   Maybe it was a intern lol ! don estaban 12/08/16 05:02:52 PM
#3701   Load 'em up... heading back to the $4.00 wickw50 12/08/16 10:18:52 AM
#3700   that is funny but,,he needs money for xmas kingsransome 12/07/16 04:50:30 PM
#3699   wouldn't be surprised if more form 4's to come budmgd 12/07/16 04:45:22 PM
#3698   Actually that's Glenn stockwinner 12/07/16 04:41:59 PM
#3697   An insider picked 1k shares haha What a joke stockwinner 12/07/16 04:38:36 PM
#3696   Looks like this may go down to the Sinjin LaGrange 12/07/16 04:29:29 PM
#3695   loading,,accumulation has been building at 1.40 pps,,hold tite myop kingsransome 12/07/16 11:34:34 AM
#3694   LMAO, he said he will promote R&D bleu22 12/07/16 10:30:46 AM
#3693   Trump said will lower drug prices stockwinner 12/07/16 10:01:33 AM
#3692   What is the reason for the dramatic drop. Loading? Dgoff 12/07/16 09:48:49 AM
#3691   And a pull back it is. What will Dgoff 12/07/16 08:49:25 AM
#3690   Agreed but I expect a bit of a Sinjin LaGrange 12/07/16 08:44:44 AM
#3689   nice day looking for nice spike imo steez 12/07/16 12:54:58 AM
#3688   * * $NVAX Video Chart 12-06-16 * * ClayTrader 12/06/16 04:54:42 PM
#3687   Not sure if today's action is related to simba1 12/06/16 03:16:16 PM
#3686   Coming soon, hopefully bleu22 12/06/16 02:32:06 PM
#3685   I'd love a gap up to about 3-5 dollars Ross92 12/06/16 02:31:26 PM
#3684   I think there may be a conference call tomorrow? Ross92 12/06/16 02:09:45 PM
#3683   YUP bleu22 12/06/16 02:02:21 PM
#3682   Big buys all Something brewing Let's wait and see Glta stockwinner 12/06/16 02:01:56 PM
#3681   Very possible SQEEZE COMING bleu22 12/06/16 01:42:38 PM
#3680   STEEZ loading the boat some thing steez 12/06/16 01:20:39 PM
#3679   thoughts on whats goin on here? mikekrane 12/06/16 01:17:36 PM
#3678   Seeing good movement today. Keep going Dgoff 12/06/16 01:14:27 PM
#3677   This going to be the sleeper stock of 2017. Sinjin LaGrange 12/04/16 07:46:05 PM
#3676   It looks like things are starting to stabilize Sinjin LaGrange 12/02/16 04:19:11 PM
#3674   I think a lot of these beaten down Atlanta1 12/02/16 10:38:59 AM
#3673   I have a ways to go @1.66 Dgoff 12/02/16 10:36:14 AM
#3672   $NVAX acting like it may come off the Atlanta1 12/02/16 10:24:31 AM
#3671   THe motley fool may be short nvax. the gipper 12/02/16 08:23:39 AM
#3670   today may be the start of a biopharma rebound. Atlanta1 12/02/16 07:51:21 AM
#3669   How far down will it go before something Dgoff 12/02/16 05:32:05 AM
#3668   Without positive news, this stock will be going down. Mcgill 12/02/16 01:05:01 AM
#3667   Watch in the end, Sanofi will probably try lakingsphan0427 12/01/16 06:15:02 PM
#3666   1.18 was not the low. Atlanta1 12/01/16 12:58:06 PM
#3665   hope you are right. someone posted a simba1 12/01/16 12:56:57 PM
#3664   as tax loss selling subsides, I think we Atlanta1 12/01/16 12:12:12 PM
#3663   SANOFI(SNY) partners with MYMETICS(MYMX) for influenza vaccine corpus 12/01/16 11:41:14 AM
#3662   $NVAX - back in avg. sub $1.21 Atlanta1 12/01/16 09:56:31 AM
#3661   "Novavax, Inc. (NASDAQ:NVAX), the company developing recombinant vaccines blulotus 12/01/16 07:24:49 AM
#3660 simba1 11/30/16 08:24:40 PM
#3659   Agreed, I am an NVAX believer. Added simba1 11/30/16 06:17:35 PM
#3658   the post election pharma trade is fading, while Atlanta1 11/30/16 06:08:54 PM
#3657   I don't understand the selling this low. simba1 11/30/16 05:56:06 PM
#3656   Hoping NVAX is working on H5N8 (recent cases simba1 11/30/16 05:50:51 PM
#3655   Novavax would never sell out for 1.30 a Juice Newton 11/29/16 08:54:53 PM
#3654   lots of buys today,,,any good ?. blulotus 11/29/16 06:16:44 PM
#3653   budmgd, just a suspicion. Any time I the gipper 11/29/16 08:55:23 AM
#3652   NVAX potential takeover target at this low price. simba1 11/26/16 11:06:22 AM